Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
Guest Information
发布时间: 2021 - 08 - 19
点击次数: 0
Positions: Managing Director   Deputy head of research  Head of Healthcare Research
Company: Industrial Securities Co. Ltd
个人简介:
Jiaxi XU, Managing director, Deputy head of research, Head of healthcare, Industrial Securities Co. Ltd.Dr. Xu received his Ph.D. degree in State Key Laboratory of Genetic Engineering Fudan Univ. As a renowned healthcare analyst in China, Dr. Xu has over 10 years of experience in healthcare investment research and ranks No.1 for 6 times from 2014-2020 (New Fortune Analyst Ranking). He also earned multiple awards like Starmine, Forbes, IAMAC Awards etc. His team is now one of largest healthcare research teams in China and covers over 130 Mainland China, HK, US listed companies.Dr. Xu is an Editorial Board Member of Progress in Pharmaceutical Sciences (Journal of Chinese Pharmaceutical Association) and advisor for State Key Laboratory of Translational Medicine & Innovative Drug Development. He was also awarded Shanghai Financial Youth Talent and Shanghai Youth Post Expert.
发布时间: 2021 - 08 - 19
点击次数: 0
Positions: Venture Partner
Company: Qiming Venture
个人简介:
Ms. Amy Tang is a Venture Partner at Qiming Venture Partners. Amy previously worked in Morningside Ventures for 13 years (2002~2015). in charge of its Beijing office. Amy invested and managed dozens of early stage biotech portfolios during this period. Up till now, most of the investments have exited via IPOs or M&A with multiple returns.Prior to joining Morningside, Amy worked in GSK as a regulatory manager for five years and product manager for two years.Amy earned her master's degree in Chinese Academy of Sciences and a bachelor's degree from Shen Yang Pharmaceutical University. Amy is also a graduate of EMBA course of Cheung Kong Graduate School of Business (CKGSB).
发布时间: 2021 - 08 - 19
点击次数: 0
Positions: Vice President, Global Issuer Services
Company: Hong Kong Exchanges and Clearing Limited
个人简介:
Ms. Zhang joined the Listing Department of HKEx in 2011 and was responsible for processing applications for IPO listing application, and coordinating listing policy initiatives and developments. Ms. Zhang internally transferred to Beijing Representative Office since August 2015. Her key focus is on market development introducing and promoting the HKEX IPO platform to corporates, investors and financial institutions in Mainland China.